17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study
Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention.
Gespeichert in:
| Autor*in: |
Stringer, Elizabeth M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9462 |
|---|
| Übergeordnetes Werk: |
Enthalten in: IS - Domingues, Sara ELSEVIER, 2018, AJOG, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:215 ; year:2016 ; number:1 ; pages:1051-10512 ; extent:9462 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ajog.2016.01.180 |
|---|
| Katalog-ID: |
ELV014497603 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV014497603 | ||
| 003 | DE-627 | ||
| 005 | 20230623114232.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajog.2016.01.180 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016020000014.pica |
| 035 | |a (DE-627)ELV014497603 | ||
| 035 | |a (ELSEVIER)S0002-9378(16)00230-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 100 | 1 | |a Stringer, Elizabeth M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study |
| 264 | 1 | |c 2016 | |
| 300 | |a 9462 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. | ||
| 650 | 7 | |a 17OHP-C |2 Elsevier | |
| 650 | 7 | |a prematurity |2 Elsevier | |
| 650 | 7 | |a implementation |2 Elsevier | |
| 650 | 7 | |a prevention |2 Elsevier | |
| 700 | 1 | |a Vladutiu, Catherine J. |4 oth | |
| 700 | 1 | |a Manuck, Tracy |4 oth | |
| 700 | 1 | |a Verbiest, Sarah |4 oth | |
| 700 | 1 | |a Ollendorff, Arthur |4 oth | |
| 700 | 1 | |a Stringer, Jeffrey S.A. |4 oth | |
| 700 | 1 | |a Menard, M. Kathryn |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Domingues, Sara ELSEVIER |t IS |d 2018 |d AJOG |g Orlando, Fla |w (DE-627)ELV000288284 |
| 773 | 1 | 8 | |g volume:215 |g year:2016 |g number:1 |g pages:1051-10512 |g extent:9462 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajog.2016.01.180 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 215 |j 2016 |e 1 |h 1051-10512 |g 9462 |y 215.2016, 1, 105.e1-, (9462 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
e m s em ems |
|---|---|
| matchkey_str |
stringerelizabethmvladutiucatherinejmanu:2016----:7yrxpoetrncpot1opcvrgaoglgbeoedlvrna2otcrlnhsiasn |
| hierarchy_sort_str |
2016 |
| publishDate |
2016 |
| allfields |
10.1016/j.ajog.2016.01.180 doi GBVA2016020000014.pica (DE-627)ELV014497603 (ELSEVIER)S0002-9378(16)00230-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Stringer, Elizabeth M. verfasserin aut 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study 2016 9462 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention Elsevier Vladutiu, Catherine J. oth Manuck, Tracy oth Verbiest, Sarah oth Ollendorff, Arthur oth Stringer, Jeffrey S.A. oth Menard, M. Kathryn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:215 year:2016 number:1 pages:1051-10512 extent:9462 https://doi.org/10.1016/j.ajog.2016.01.180 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 215 2016 1 1051-10512 9462 215.2016, 1, 105.e1-, (9462 S.) 045F 610 |
| spelling |
10.1016/j.ajog.2016.01.180 doi GBVA2016020000014.pica (DE-627)ELV014497603 (ELSEVIER)S0002-9378(16)00230-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Stringer, Elizabeth M. verfasserin aut 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study 2016 9462 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention Elsevier Vladutiu, Catherine J. oth Manuck, Tracy oth Verbiest, Sarah oth Ollendorff, Arthur oth Stringer, Jeffrey S.A. oth Menard, M. Kathryn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:215 year:2016 number:1 pages:1051-10512 extent:9462 https://doi.org/10.1016/j.ajog.2016.01.180 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 215 2016 1 1051-10512 9462 215.2016, 1, 105.e1-, (9462 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.ajog.2016.01.180 doi GBVA2016020000014.pica (DE-627)ELV014497603 (ELSEVIER)S0002-9378(16)00230-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Stringer, Elizabeth M. verfasserin aut 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study 2016 9462 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention Elsevier Vladutiu, Catherine J. oth Manuck, Tracy oth Verbiest, Sarah oth Ollendorff, Arthur oth Stringer, Jeffrey S.A. oth Menard, M. Kathryn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:215 year:2016 number:1 pages:1051-10512 extent:9462 https://doi.org/10.1016/j.ajog.2016.01.180 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 215 2016 1 1051-10512 9462 215.2016, 1, 105.e1-, (9462 S.) 045F 610 |
| allfieldsGer |
10.1016/j.ajog.2016.01.180 doi GBVA2016020000014.pica (DE-627)ELV014497603 (ELSEVIER)S0002-9378(16)00230-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Stringer, Elizabeth M. verfasserin aut 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study 2016 9462 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention Elsevier Vladutiu, Catherine J. oth Manuck, Tracy oth Verbiest, Sarah oth Ollendorff, Arthur oth Stringer, Jeffrey S.A. oth Menard, M. Kathryn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:215 year:2016 number:1 pages:1051-10512 extent:9462 https://doi.org/10.1016/j.ajog.2016.01.180 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 215 2016 1 1051-10512 9462 215.2016, 1, 105.e1-, (9462 S.) 045F 610 |
| allfieldsSound |
10.1016/j.ajog.2016.01.180 doi GBVA2016020000014.pica (DE-627)ELV014497603 (ELSEVIER)S0002-9378(16)00230-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Stringer, Elizabeth M. verfasserin aut 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study 2016 9462 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention Elsevier Vladutiu, Catherine J. oth Manuck, Tracy oth Verbiest, Sarah oth Ollendorff, Arthur oth Stringer, Jeffrey S.A. oth Menard, M. Kathryn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:215 year:2016 number:1 pages:1051-10512 extent:9462 https://doi.org/10.1016/j.ajog.2016.01.180 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 215 2016 1 1051-10512 9462 215.2016, 1, 105.e1-, (9462 S.) 045F 610 |
| language |
English |
| source |
Enthalten in IS Orlando, Fla volume:215 year:2016 number:1 pages:1051-10512 extent:9462 |
| sourceStr |
Enthalten in IS Orlando, Fla volume:215 year:2016 number:1 pages:1051-10512 extent:9462 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
17OHP-C prematurity implementation prevention |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
IS |
| authorswithroles_txt_mv |
Stringer, Elizabeth M. @@aut@@ Vladutiu, Catherine J. @@oth@@ Manuck, Tracy @@oth@@ Verbiest, Sarah @@oth@@ Ollendorff, Arthur @@oth@@ Stringer, Jeffrey S.A. @@oth@@ Menard, M. Kathryn @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000288284 |
| dewey-sort |
3610 |
| id |
ELV014497603 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV014497603</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623114232.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2016.01.180</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016020000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV014497603</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(16)00230-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Stringer, Elizabeth M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9462</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">17OHP-C</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prematurity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">implementation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prevention</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vladutiu, Catherine J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manuck, Tracy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Verbiest, Sarah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ollendorff, Arthur</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stringer, Jeffrey S.A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menard, M. Kathryn</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:215</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:1051-10512</subfield><subfield code="g">extent:9462</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2016.01.180</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">215</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">1051-10512</subfield><subfield code="g">9462</subfield><subfield code="y">215.2016, 1, 105.e1-, (9462 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Stringer, Elizabeth M. |
| spellingShingle |
Stringer, Elizabeth M. ddc 610 ddc 570 fid BIODIV Elsevier 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study |
| authorStr |
Stringer, Elizabeth M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000288284 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 570 VZ BIODIV DE-30 fid 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention Elsevier |
| topic |
ddc 610 ddc 570 fid BIODIV Elsevier 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention |
| topic_unstemmed |
ddc 610 ddc 570 fid BIODIV Elsevier 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention |
| topic_browse |
ddc 610 ddc 570 fid BIODIV Elsevier 17OHP-C Elsevier prematurity Elsevier implementation Elsevier prevention |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
c j v cj cjv t m tm s v sv a o ao j s s js jss m k m mk mkm |
| hierarchy_parent_title |
IS |
| hierarchy_parent_id |
ELV000288284 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
| hierarchy_top_title |
IS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000288284 |
| title |
17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study |
| ctrlnum |
(DE-627)ELV014497603 (ELSEVIER)S0002-9378(16)00230-1 |
| title_full |
17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study |
| author_sort |
Stringer, Elizabeth M. |
| journal |
IS |
| journalStr |
IS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
1051 |
| author_browse |
Stringer, Elizabeth M. |
| container_volume |
215 |
| physical |
9462 |
| class |
610 610 DE-600 570 VZ BIODIV DE-30 fid |
| format_se |
Elektronische Aufsätze |
| author-letter |
Stringer, Elizabeth M. |
| doi_str_mv |
10.1016/j.ajog.2016.01.180 |
| dewey-full |
610 570 |
| title_sort |
17-hydroxyprogesterone caproate (17ohp-c) coverage among eligible women delivering at 2 north carolina hospitals in 2012 and 2013: a retrospective cohort study |
| title_auth |
17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study |
| abstract |
Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. |
| abstractGer |
Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. |
| abstract_unstemmed |
Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study |
| url |
https://doi.org/10.1016/j.ajog.2016.01.180 |
| remote_bool |
true |
| author2 |
Vladutiu, Catherine J. Manuck, Tracy Verbiest, Sarah Ollendorff, Arthur Stringer, Jeffrey S.A. Menard, M. Kathryn |
| author2Str |
Vladutiu, Catherine J. Manuck, Tracy Verbiest, Sarah Ollendorff, Arthur Stringer, Jeffrey S.A. Menard, M. Kathryn |
| ppnlink |
ELV000288284 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.ajog.2016.01.180 |
| up_date |
2024-07-06T21:41:43.368Z |
| _version_ |
1803867498343301120 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV014497603</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623114232.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2016.01.180</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016020000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV014497603</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(16)00230-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Stringer, Elizabeth M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9462</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Although a weekly injection of 17-hydroxyprogestone caproate is recommended for preventing recurrent preterm birth, clinical experience in North Carolina suggested that many eligible patients were not receiving the intervention.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">17OHP-C</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prematurity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">implementation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prevention</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vladutiu, Catherine J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manuck, Tracy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Verbiest, Sarah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ollendorff, Arthur</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stringer, Jeffrey S.A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menard, M. Kathryn</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:215</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:1051-10512</subfield><subfield code="g">extent:9462</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2016.01.180</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">215</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">1051-10512</subfield><subfield code="g">9462</subfield><subfield code="y">215.2016, 1, 105.e1-, (9462 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4009514 |